COLOSENSE Trademark

Trademark Overview

On Thursday, November 11, 2021, a trademark application was filed for COLOSENSE with the United States Patent and Trademark Office. The USPTO has given the COLOSENSE trademark a serial number of 97119484. The federal status of this trademark filing is SU - FINAL REFUSAL - MAILED as of Monday, September 30, 2024. This trademark is owned by Geneoscopy, LLC. The COLOSENSE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Compilation of information into computer databases, namely, inputting and collection of data and information in the field of cancer information for treatment and diagnostic purposes
colosense

General Information

Serial Number97119484
Word MarkCOLOSENSE
Filing DateThursday, November 11, 2021
Status809 - SU - FINAL REFUSAL - MAILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Goods and ServicesCompilation of information into computer databases, namely, inputting and collection of data and information in the field of cancer information for treatment and diagnostic purposes

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code035
First Use Anywhere DateFriday, September 1, 2023
First Use In Commerce DateFriday, September 1, 2023

Trademark Owner History

Party NameGeneoscopy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63146
Party NameGeneoscopy, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Louis, MO 63146

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021NEW APPLICATION ENTERED
Tuesday, August 23, 2022ASSIGNED TO EXAMINER
Monday, August 29, 2022NON-FINAL ACTION WRITTEN
Monday, August 29, 2022NON-FINAL ACTION E-MAILED
Monday, August 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 16, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, December 7, 2022ASSIGNED TO PETITION STAFF
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2023SOU EXTENSION 1 FILED
Tuesday, June 20, 2023SOU EXTENSION 1 GRANTED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023USE AMENDMENT FILED
Monday, December 18, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, January 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 8, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, February 12, 2024CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 20, 2024ASSIGNED TO EXAMINER
Tuesday, March 19, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 19, 2024NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, May 14, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, June 18, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 18, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2024DIVISIONAL PROCESSING COMPLETE
Monday, September 30, 2024FINAL REFUSAL E-MAILED
Monday, September 30, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 30, 2024SU - FINAL REFUSAL - WRITTEN

Related Keywords

colosense information cancer field treatment diagnostic purposes data collection computer databases